Findings from the global FRESCO-2 trial showed that a drug called fruquintinib (fru-kin-tih-nib) significantly improved overall survival and progression-free survival in patients with metastatic colorectal cancer that has stopped responding to treatment (also known as refractory metastatic colorectal cancer). The findings were presented at the European Society for Medical Oncology ...

Findings from a study published in the Journal of Clinical Oncology demonstrated that among patients who were receiving adjuvant (post-surgical) therapy for stage III colon cancer, those that participated in greater volumes of recreational physical activity, longer durations of light- to moderate-intensity aerobic physical activity, or any vigorous-intensity aerobic physical ...

Ulcerative colitis is a chronic inflammatory bowel disease that affects the lining of the large intestine (colon and rectum). It causes inflammation and ulcers (sores) that result in the following signs and symptoms: •Diarrhea, often with blood or pus •Abdominal pain and cramping •Rectal pain •Rectal bleeding (passing small amounts ...

Crohn’s disease is a chronic (long-term) inflammatory disease that can affect any part of the gastrointestinal tract, including the mouth, throat, esophagus, stomach, small intestine, large intestine, rectum, and anus, though it usually targets the end of the small intestine or the colon (large intestine). Though experts are not certain ...